IDF23-0498 Subgroup analysis of Phase 3 study of dapagliflozin, glimepiride and metformin ER FDC in T2DM patients with HbA1c 9% –11%

Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Tags: Diabetes in Crises: Natural Disasters and Conflict Source Type: research